Accueil › Cancer de la prostate › Texas › San Antonio
Essais cliniques pour Cancer de la prostate à San Antonio, TX
28 études pour Cancer de la prostate recherchent des participants dans et autour de San Antonio (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Audie L Murphy VA Hospital, San Antonio
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Recrutement en coursPhase 2/3
- Urology San Antonio, San Antonio
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recrutement en coursPhase 3
- Urology San Antonio, San Antonio
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Recrutement en coursPhase 3
- Research Site, San Antonio
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Recrutement en coursPhase 3
- The Urology Place, San Antonio
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Recrutement en coursPhase 3
- Brooke Army Medical Center, Fort Sam Houston · à 4 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
Recrutement en coursÉtude observationnelle
- University of Texas Health Science Center, San Antonio, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Recrutement en coursPhase 1
- START San Antonio, San Antonio
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Recrutement en coursÉtude observationnelle
- The Urology Place, Inc., San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Research Site, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
IDOV-Immune for Advanced Solid Tumors
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Recrutement en coursPhase 1/2
- START, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Recrutement en coursPhase 1
- USA Clinical Trials, San Antonio
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Recrutement en coursPhase 1/2
- UT Health, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology San Antonio, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Recrutement en coursPhase 1/2
- START San Antonio, San Antonio
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Recrutement en coursPhase 3
- Audie L Murphy VA Hospital, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- Exelixis Clinical Site #3, San Antonio
Customized TULSA-PRO Ablation Registry
Recrutement en coursÉtude observationnelle
- Urology Place, San Antonio
Essais pour Cancer de la prostate dans d'autres villes
- New York City, NY103 études
- Houston, TX76 études
- Los Angeles, CA61 études
- Boston, MA59 études
- St. Louis, MO46 études
- Chicago, IL45 études
- San Francisco, CA45 études
- Philadelphia, PA44 études
- Baltimore, MD43 études
- Nashville, TN42 études
- Seattle, WA42 études
- Washington, DC38 études
Autres études à San Antonio
- Cancer du poumon non à petites cellules59 études
- Cancer colorectal46 études
- Cancer du sein46 études
- Cancer métastatique44 études
- Cancer (tous types)41 études
- Obésité40 études
- Diabète de type 237 études
- Surpoids34 études
- Cancer de l'ovaire31 études
- Cancer du pancréas31 études
- Cancer de l'endomètre27 études
- Cancer du poumon26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.